Walleye Capital LLC Sorrento Therapeutics, Inc. Transaction History

Walleye Capital LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	SELL	$1.24 - $2.33 $207,949 - $390,743	-167,701 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$2.0 - $4.9 $335,402 - $821,734	167,701 New	167,701 $391,000
Q2 2021 Aug 16, 2021	SELL	$6.35 - $10.0 $78,936 - $124,310	-12,431 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$7.03 - $16.51 $87,389 - $205,235	12,431 New	12,431 $103,000

5.47M

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.